Phase II Trial With Metronomic, Capecitabine Plus Oral Vinorelbine for Metastatic Breast Cancer

Phase 2 Completed 110 enrolled University of Aarhus Pierre Fabre Laboratories · collab

RandomizedParallel-groupOpen-labelTreatment

The study hypothesis is that metronomic treatment is more efficient than standard treatment.

Evaluation	Drug	Modality	Dose	Route
Subject	Capecitabine	Small molecule	1000 mg/m2	Oral
Subject	Vinorelbine	Small molecule	50 mg	Oral
Subject	Vinorelbine	Small molecule	60 mg/m2	Oral